Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer.

Krig SR, Frietze S, Simion C, Miller JK, Fry WH, Rafidi H, Kotelawala L, Qi L, Griffith OL, Gray JW, Carraway KL 3rd, Sweeney C.

Mol Cancer Res. 2011 Oct;9(10):1406-17. doi: 10.1158/1541-7786.MCR-11-0227. Epub 2011 Aug 5.

PMID:
21821674
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.

Tolhurst RS, Thomas RS, Kyle FJ, Patel H, Periyasamy M, Photiou A, Thiruchelvam PT, Lai CF, Al-Sabbagh M, Fisher RA, Barry S, Crnogorac-Jurcevic T, Martin LA, Dowsett M, Charles Coombes R, Kamalati T, Ali S, Buluwela L.

Breast Cancer Res Treat. 2011 Jul;128(2):357-68. doi: 10.1007/s10549-010-1122-6. Epub 2010 Aug 22.

PMID:
20730598
[PubMed - indexed for MEDLINE]
3.

Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.

Ellison-Zelski SJ, Alarid ET.

Mol Cancer. 2010 Sep 29;9:263. doi: 10.1186/1476-4598-9-263.

PMID:
20920219
[PubMed - indexed for MEDLINE]
Free PMC Article
4.
5.

High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.

Marot D, Bieche I, Aumas C, Esselin S, Bouquet C, Vacher S, Lazennec G, Perricaudet M, Kuttenn F, Lidereau R, de Roux N.

Endocr Relat Cancer. 2007 Sep;14(3):691-702.

PMID:
17914099
[PubMed - indexed for MEDLINE]
Free Article
6.

Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.

Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, Baak JP, Søreide JA.

Acta Oncol. 2009;48(4):514-21. doi: 10.1080/02841860802620613.

PMID:
19107621
[PubMed - indexed for MEDLINE]
7.

miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H.

Cancer Res. 2008 Jul 1;68(13):5004-8. doi: 10.1158/0008-5472.CAN-08-0180.

PMID:
18593897
[PubMed - indexed for MEDLINE]
Free Article
8.

The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells.

Jiang Z, Guo J, Shen J, Jin M, Xie S, Wang L.

J Exp Clin Cancer Res. 2012 May 3;31:42. doi: 10.1186/1756-9966-31-42.

PMID:
22553917
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.

Imachi H, Murao K, Dobashi H, Bhuyan MM, Cao X, Kontani K, Niki S, Murazawa C, Nakajima H, Kohno N, Yamashita H, Iwase H, Hayashi S, Ishida T, Yamauchi A.

Breast Cancer Res Treat. 2010 Jul;122(2):395-407. doi: 10.1007/s10549-009-0581-0. Epub 2009 Oct 22.

PMID:
19847644
[PubMed - indexed for MEDLINE]
10.

Gene expression signature of estrogen receptor alpha status in breast cancer.

Abba MC, Hu Y, Sun H, Drake JA, Gaddis S, Baggerly K, Sahin A, Aldaz CM.

BMC Genomics. 2005 Mar 11;6:37.

PMID:
15762987
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.

Motomura K, Ishitobi M, Komoike Y, Koyama H, Nagase H, Inaji H, Noguchi S.

Oncology. 2010;79(1-2):55-61. doi: 10.1159/000319540. Epub 2010 Nov 11.

PMID:
21071990
[PubMed - indexed for MEDLINE]
12.

Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR, Tsimelzon A, Wang T, Hilsenbeck SG, Chamness GC, Andò S, Fuqua SA.

J Natl Cancer Inst. 2011 Apr 6;103(7):538-52. doi: 10.1093/jnci/djr058. Epub 2011 Mar 29.

PMID:
21447808
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.

Horm Cancer. 2012 Aug;3(4):147-59. doi: 10.1007/s12672-012-0111-0. Epub 2012 Apr 3.

PMID:
22476979
[PubMed - indexed for MEDLINE]
15.

RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.

Thaler S, Schmidt M, Schad A, Sleeman JP.

Oncogene. 2012 Nov 22;31(47):4912-22. doi: 10.1038/onc.2011.658. Epub 2012 Jan 23.

PMID:
22266866
[PubMed - indexed for MEDLINE]
16.

Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.

Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M.

J Cell Physiol. 2004 Sep;200(3):440-50.

PMID:
15254972
[PubMed - indexed for MEDLINE]
17.

The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.

Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC.

Cancer Res. 2010 Feb 1;70(3):1184-94. doi: 10.1158/0008-5472.CAN-09-3068. Epub 2010 Jan 19.

PMID:
20086172
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance.

Lupien M, Meyer CA, Bailey ST, Eeckhoute J, Cook J, Westerling T, Zhang X, Carroll JS, Rhodes DR, Liu XS, Brown M.

Genes Dev. 2010 Oct 1;24(19):2219-27. doi: 10.1101/gad.1944810.

PMID:
20889718
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.

Al-Dhaheri M, Wu J, Skliris GP, Li J, Higashimato K, Wang Y, White KP, Lambert P, Zhu Y, Murphy L, Xu W.

Cancer Res. 2011 Mar 15;71(6):2118-28. doi: 10.1158/0008-5472.CAN-10-2426. Epub 2011 Jan 31.

PMID:
21282336
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response.

Bayliss J, Hilger A, Vishnu P, Diehl K, El-Ashry D.

Clin Cancer Res. 2007 Dec 1;13(23):7029-36.

PMID:
18056179
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk